<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>TRAF2 has an important function in mediating the TNF-R signaling pathway toward activation of NF-ÎºB and JNKs </plain></SENT>
<SENT sid="1" pm="."><plain>Here we reveal a novel function of TRAF2 in the epidermal growth factor (EGF) signaling pathway </plain></SENT>
<SENT sid="2" pm="."><plain>Knockdown of TRAF2 blocked EGF-induced AP-1 activity and anchorage- independent cell transformation </plain></SENT>
<SENT sid="3" pm="."><plain>Notably, we showed that EGF induces ribosomal S6 kinase 2 (RSK2) ubiquitination, and knocking down TRAF2 suppresses ubiquitination of RSK2 induced by EGF </plain></SENT>
<SENT sid="4" pm="."><plain>We also found that TRAF2 affects RSK2 activity through RSK2 ubiquitination </plain></SENT>
<SENT sid="5" pm="."><plain>RSK2 plays a critical role in AP-1 activity mediated through CREB and c-Fos, which regulates anchorage-independent cell transformation </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, TRAF2 is overexpressed in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and required for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> development, suggesting that TRAF2 might be a potential molecular target for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention and treatment </plain></SENT>
</text></document>